Split (1)

train · 137 rows

Name stringlengths 8 13	ELISA Cardiolipin float64 0.89 16.6	ELISA KLH float64 0.78 11.4	ELISA LPS float64 0.73 11.9	ELISA ssDNA float64 0.94 18.2	ELISA dsDNA float64 0.82 16.9	ELISA Insulin float64 0.88 16	BVP ELISA float64 1.03 22.8
abituzumab	1.44	0.97	1	1.1	1.16	1.15	2.72
abrilumab	1.51	0.86	0.96	1.32	1.12	0.97	1.82
adalimumab	1.47	0.88	0.92	1.14	1.03	1	1.49
alemtuzumab	1.53	0.93	1.06	1.1	1.27	1.08	1.46
alirocumab	1.65	1.06	1.03	1.09	1.26	1.08	2.18
anifrolumab	1.3	0.96	1.26	1.13	1.12	1.16	1.62
atezolizumab	1.15	1.29	0.93	1.22	1.41	1.76	6.2
bapineuzumab	1.32	1.12	1.13	1.42	1.25	1.02	3.55
basiliximab	1.11	1.15	1.05	1.2	1.38	1.33	2.14
bavituximab	1.56	1.48	1.26	1.16	1.16	1.27	1.69
belimumab	2.15	2.34	2.74	4.56	3.9	5.97	12.23
benralizumab	1.15	1.64	1.3	1.08	1.05	1.18	1.42
bevacizumab	1.54	1.1	1.05	1.31	1.34	1.38	2.78
bimagrumab	1.66	1.47	1.45	1.78	1.63	1.3	5.33
blosozumab	16.56	4.1	10.74	14.86	16.85	15.95	12.85
bococizumab	14	10.72	11.55	16.01	14.52	14.18	18.88
brentuximab	2.7	1.29	1.11	16.89	2.05	1.23	2.24
briakinumab	2.35	1.83	1.72	15.68	3.43	3.97	10.22
brodalumab	1.62	0.92	1.1	2.86	1.32	1.04	2.93
canakinumab	1.42	0.96	1.05	1.2	1.36	1.18	2.55
carlumab	1.52	1.9	2.3	2.7	3.83	4.32	8.88
certolizumab	1.34	0.98	1	1.2	1.23	1.11	1.65
cetuximab	0.97	0.93	1.11	1.03	1.19	1.33	1.09
cixutumumab	4.25	2.95	3.12	3.95	3.71	4.62	11.9
clazakizumab	1.45	1.32	1.2	1.12	1.22	1.37	4.12
codrituzumab	2.49	5.2	11.65	14	10.43	12.74	14.87
crenezumab	1.14	1.07	1.11	1.09	1.16	1.23	2.78
dacetuzumab	1.01	1.03	1.06	1.07	1.14	1.17	1.34
daclizumab	2.06	0.88	0.94	1.04	1.14	1.02	1.41
dalotuzumab	2.94	1.52	2.05	3.87	4.11	2.9	8.25
daratumumab	1.47	1.01	1.02	1.15	1.46	1.18	3.15
denosumab	2.15	4.8	1.87	12.57	8.65	5.47	17.75
dinutuximab	1.06	1.04	0.76	1.08	0.93	1.31	1.69
drozitumab	1.51	0.9	0.97	1.11	1.12	0.98	1.48
duligotuzumab	15.83	4.83	5.38	9.52	7.23	8.45	9.63
dupilumab	1.81	8.96	8.07	8.3	12.5	12.53	19.27
eculizumab	1.09	0.95	0.77	1.01	0.88	1.05	3
efalizumab	0.96	1.05	0.95	1.04	0.83	1.07	1.24
eldelumab	1.22	1.11	1.06	1.06	1.08	1.14	1.75
elotuzumab	1.39	0.91	0.78	0.98	0.82	0.99	1.26
emibetuzumab	2.78	2.29	2.23	3.18	3.93	5.39	8.33
enokizumab	1.65	0.97	1.04	1.14	1.21	1.04	3.24
epratuzumab	2.26	1.05	1.08	1.55	1.59	1.32	2.34
etrolizumab	1.01	0.98	1.07	3.96	4.85	1.23	4.23
evolocumab	3.42	1.13	1.04	1.41	1.93	1.59	1.75
farletuzumab	1.54	0.78	0.95	1.02	1.17	0.97	1.32
fasinumab	1.53	0.83	0.95	1.18	1.21	1.24	2.53
fezakinumab	1.48	1.07	1.09	1.17	1.13	0.94	2.15
ficlatuzumab	1.67	0.89	0.98	1.07	1.25	0.93	1.23
figitumumab	1.58	1.44	1.32	8.18	2.75	2.08	5.65
fletikumab	1.34	0.82	0.92	1.06	1.05	0.95	1.41
foralumab	1.56	1.19	1.28	16.68	6.42	1.48	4.71
fresolimumab	1.32	0.93	1.12	1.21	1.45	1.78	3.51
fulranumab	3.04	1.42	1.38	1.79	1.73	1.72	6.92
galiximab	1.22	1.1	1.23	1.25	1.26	1.23	3.81
ganitumab	1.78	1.24	1.04	1.26	1.35	1.11	4.91
gantenerumab	14.37	11.43	11.42	16.35	15.27	14.09	22.75
gemtuzumab	1.24	0.93	1.06	1.08	1.2	0.97	1.7
gevokizumab	1.28	1	1.31	1.14	1.14	1.21	1.93
girentuximab	1.18	0.93	1.01	1.17	1.17	1.08	1.39
glembatumumab	1.04	1.22	0.98	1.04	0.88	1.22	2.22
golimumab	1	2.28	1.07	1.1	1.08	1.31	2.71
guselkumab	1.94	1.55	1.3	1.6	1.37	1.49	5.87
ibalizumab	0.91	1.08	1.21	0.94	0.83	0.99	1.13
imgatuzumab	1.83	2.49	5.42	6.9	6.62	6.82	11.77
infliximab	1.02	1	1.04	1.08	1.03	1.05	1.37
inotuzumab	2.42	1.38	1.2	9.69	2.76	1.63	5.4
ipilimumab	1.32	0.94	0.94	1.06	1.03	1.03	1.69
ixekizumab	7.33	4.15	6.88	10.44	11.29	12.69	10.4
lampalizumab	0.94	0.91	1.26	1.04	1.22	1.28	1.34
lebrikizumab	0.98	0.9	0.78	1.01	0.98	1.12	1.46
lenzilumab	15.32	11.16	11.9	18.18	15.55	14.64	19.6
lintuzumab	1.23	0.88	0.95	1.1	1.12	0.99	1.25
lirilumab	1.3	0.97	1.03	1.27	1.47	1.58	3.55
lumiliximab	1.07	1.03	1.36	1.04	1.14	1.18	2.22
matuzumab	1.34	0.85	1.05	1.04	1.17	0.91	1.03
mavrilimumab	1.08	1.09	1.24	1.09	1.8	0.98	2.16
mepolizumab	1.65	0.8	0.96	1.01	1.13	1.23	1.05
mogamulizumab	1.31	1.09	0.99	1.16	1.18	0.98	2.17
motavizumab	1.98	1.03	0.99	1.12	1.16	1.09	5.36
muromonab	1.68	1.17	1.05	1.38	1.71	1.47	3.94
natalizumab	1.39	0.81	0.99	1.13	1.12	0.93	1.52
necitumumab	1.42	0.91	1.01	1	1.04	0.9	1.31
nimotuzumab	1.58	1.42	1.1	1.28	1.14	1.39	3.42
nivolumab	1.53	0.88	1.01	1.12	1.29	1.08	1.32
obinutuzumab	0.96	0.94	0.84	0.99	0.93	1.05	1.63
ocrelizumab	1.3	1.1	0.95	1.22	1.04	1.16	1.67
ofatumumab	1.53	0.92	1.07	1.08	1.13	1	1.18
olaratumab	1.61	1.06	1.13	1.43	1.48	1.17	2.58
olokizumab	1.21	1.18	1.12	1.08	1.05	1.01	1.23
omalizumab	1.41	0.93	0.94	1.06	1.3	1.04	1.17
onartuzumab	1.44	0.94	1.09	1.11	1.14	1	1.19
otelixizumab	1.17	1.09	1.12	1.04	1.03	1.31	1.4
otlertuzumab	1.07	1.13	1.07	1.13	1.33	1.3	1.78
ozanezumab	3.13	1.28	1.47	2.32	2.47	1.5	4.45
palivizumab	1.54	0.88	1.01	1.12	1.21	0.96	2.88
panitumumab	1.5	0.87	0.98	1.04	1.07	0.91	1.18
panobacumab	1.49	0.96	1.11	1.7	1.06	0.96	1.9
parsatuzumab	15.53	3.26	5.45	14.02	15.81	6.2	17.4
patritumab	3.54	1.6	1.64	2.17	2.22	2.91	4.35

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.